pazopanib — integMET

Metabolite details

Identifier: CUIHSIWYWATEQL-UHFFFAOYSA-N
InChI Key: CUIHSIWYWATEQL-UHFFFAOYSA-N
IUPAC name: 5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzenesulfonamide
Preferred name: pazopanib
INN name: pazopanib
Synonym: GW 78603
ChEBI: CHEBI:71219

R-HSA-1226099 - Signaling by FGFR in disease
R-HSA-162582 - Signal Transduction
R-HSA-1643685 - Disease
R-HSA-1839126 - FGFR2 mutant receptor activation
R-HSA-186797 - Signaling by PDGF
R-HSA-2023837 - Signaling by FGFR2 amplification mutants
R-HSA-2033519 - Activated point mutants of FGFR2
R-HSA-5213460 - RIPK1-mediated regulated necrosis
R-HSA-5218859 - Regulated Necrosis
R-HSA-5357801 - Programmed Cell Death
R-HSA-5655253 - Signaling by FGFR2 in disease
R-HSA-5663202 - Diseases of signal transduction by growth factor receptors and second messengers
R-HSA-5675482 - Regulation of necroptotic cell death
R-HSA-9006934 - Signaling by Receptor Tyrosine Kinases
R-HSA-9671555 - Signaling by PDGFR in disease
R-HSA-9674428 - PDGFR mutants bind TKIs